英特格拉生命科學 IART 深 滬
已收盤 05-22 16:00:00 美东时间
15.10
-0.020
-0.13%
華盛通- 最 高15.385
- 今 開15.11
- 成交量 81.46万股
- 最 低 14.825
- 昨 收 15.12
- 總市值 11.75亿
- 52周最高 16.49
- 市盈率 靜 --
- 換手率 1.05%
- 52周最低 8.70
- 委 比 60.90%
- 總股本 7779.69万
- 歷史最高 77.40
- 量 比 0.85
- 振 幅 3.70%
- 歷史最低 8.36
- 每 手 1
- 風險率 1.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
Issued on behalf of Conexeu Sciences Inc. Companies mentioned: Conexeu Sciences Inc. (NASDAQ: CNXU), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Evolus, Inc. (NASDAQ: EOLS), Bi...
05-22 22:31
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Integra Lifesciences Q1 2026 Earnings Call Transcript
Integra Lifesciences (NASDAQ:IART) held its first-quarter earnings conference c...
05-05 21:44
Integra LifeSciences Holdings shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 adjusted EPS guidance above estimates.
Integra LifeSciences Holdings shares are trading higher after the company repor...
05-05 21:20
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Integra Lifesciences Sees Q2 Adj EPS $0.44-$0.52 vs $0.53 Est; Sees Sales $410.000M-$425.000M vs $425.403M Est
Integra Lifesciences (NASDAQ:IART) is looking for Q2 Adj EPS of $0.44-$0.52 vs $0.53 analyst estimate. sees sales of $410.000 million-$425.000 million vs $425.403 million analyst estimate.
05-05 18:17
Integra Lifesciences Raises FY2026 Adj EPS Guidance from $2.30-$2.40 to $2.40-$2.50 vs $2.35 Est; Affirms FY2026 Sales Guidance of $1.662B-$1.702B vs $1.674B Est
Integra Lifesciences (NASDAQ:IART) raises FY2026 Adj EPS guidance from $2.30-$2.40 to $2.40-$2.50 vs $2.35 analyst estimate. Affirms FY2026 sales outlook from $1.662 billion-$1.702 billion to $1.662 billion-$1.702
05-05 18:16
Integra Lifesciences Q1 Adj. EPS $0.54 Beats $0.41 Estimate, Sales $391.918M Beat $381.870M Estimate
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.41 by 31.71 percent. This is a 31.71 percent increase over earnings of $0.41 per share
05-05 18:15
Integra LifeSciences names Stuart Essig as CEO
Integra LifeSciences (IART) said Tuesday that Stuart Essig, chairman of Integra’s board of directors, has been appointed president and chief executive officer, effective May 1, 2026. Essig brings more...
05-05 18:07
Integra LifeSciences Announces Leadership Transition
Integra LifeSciences announced Stuart Essig as its new President and Chief Executive Officer, effective May 1, 2026. Essig, who has served as chairman of the board since 2012, brings over 30 years of experience in the medical technology industry and previously led Integra from 1997 to early 2012. Mojdeh Poul, the former CEO, is pursuing other opportunities. Additionally, Michael McBreen was appointed Chief Commercial Officer to strengthen commerc...
05-05 10:00
